Amarin Corp plc (NASDAQ: AMRN) and Eddingpharm announced an exclusive agreement for Eddingpharm to develop and commercialize Vascepa® (icosapent ethyl) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE